Jul 102020
 

By Talent4Boards Team

Talent4Boards - Great Talent builds Great Boards

– USA, CA – Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the appointment of Dr Elliott Sigal, M.D., Ph.D., to its board of directors. Dr. Sigal formerly served as EVP, CSO and President of Bristol-Myers Squibb Company Research and Development, where he played an instrumental role in bringing 14 new ...

Vir Biotechnology appoints Dr Elliott Sigal to its Board of Directors

Vir Biotechnology appoints Dr Elliott Sigal to its Board of Directors

From:: Vir Biotechnology appoints Dr Elliott Sigal to its Board of Directors

Sorry, the comment form is closed at this time.